These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1245944)

  • 1. Possible misdiagnosis of Krabbe disease.
    Wenger DA; Riccardi VM
    J Pediatr; 1976 Jan; 88(1):76-9. PubMed ID: 1245944
    [No Abstract]   [Full Text] [Related]  

  • 2. An improved method for the identification of patients and carriers of Krabbe's disease.
    Wenger DA; Sattler M; Clark C; McKelvey H
    Clin Chim Acta; 1974 Oct; 56(2):199-206. PubMed ID: 4434632
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a fluorogenic substrate, 6-hexadecanoylamino-4-methylumbelliferyl-beta-D-galactopyranoside, in the diagnosis of Krabbe disease.
    Grimm U; Zschiesche M; Widerschain G; Seidlitz G; Machill G
    J Inherit Metab Dis; 1991; 14(6):940-1. PubMed ID: 1779655
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of Krabbe disease].
    Ren XT; Yang Y; Wang CZ
    Zhonghua Er Ke Za Zhi; 2013 Jan; 51(1):69-70. PubMed ID: 23527935
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of Krabbe disease using tritiated galactosylceramides with medium-chain fatty acids.
    Parvathy MR; Ben-Yoseph Y; Mitchell DA; Nadler HL
    J Lab Clin Med; 1987 Dec; 110(6):740-6. PubMed ID: 3681116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Krabbe disease: an overview.
    Pastores GM
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S75-81. PubMed ID: 20040316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Specific Activity-Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease.
    Marques AR; Willems LI; Herrera Moro D; Florea BI; Scheij S; Ottenhoff R; van Roomen CP; Verhoek M; Nelson JK; Kallemeijn WW; Biela-Banas A; Martin OR; Cachón-González MB; Kim NN; Cox TM; Boot RG; Overkleeft HS; Aerts JM
    Chembiochem; 2017 Feb; 18(4):402-412. PubMed ID: 28000364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of galactosylceramides with uniform fatty acids as substrates in the diagnosis and carrier detection of Krabbe disease.
    Månsson JE; Svennerholm L
    Clin Chim Acta; 1982 Dec; 126(2):127-33. PubMed ID: 7151275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the accuracy of enzymatically determined carrier status for Krabbe disease by DNA-based testing.
    Randell E; Connolly-Wilson M; Duff A; Skomorowski MA; Callahan J
    Clin Biochem; 2000 Apr; 33(3):217-20. PubMed ID: 10913522
    [No Abstract]   [Full Text] [Related]  

  • 10. Galactocerebrosidase assay on dried-leukocytes impregnated in filter paper for the detection of Krabbe disease.
    Camelier M; Civallero G; De Mari J; Burin M; Giugliani R
    Clin Chim Acta; 2015 Jan; 438():178-80. PubMed ID: 25193740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of 6-hexadecanoylamino-4-methylumbelliferyl-beta-D- galactopyranoside as fluorogenic substrate of galactocerebrosidase for the diagnosis of Krabbe disease.
    Wiederschain G; Raghavan S; Kolodny E
    Clin Chim Acta; 1992 Jan; 205(1-2):87-96. PubMed ID: 1521344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of galactosylceramide in the twitcher mouse, an animal model of human globoid cell leukodystrophy.
    Kobayashi T; Shinnoh N; Kuroiwa Y
    Biochim Biophys Acta; 1986 Nov; 879(2):215-20. PubMed ID: 3094585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of Krabbe disease: galactosylceramide metabolism in cultured amniotic fluid cells.
    Kudoh T; Wenger DA
    J Pediatr; 1982 Nov; 101(5):754-7. PubMed ID: 7131154
    [No Abstract]   [Full Text] [Related]  

  • 14. [Krabbe disease].
    Suzuki Y
    Nihon Rinsho; 1973 Aug; 31(8):2469-74. PubMed ID: 4588057
    [No Abstract]   [Full Text] [Related]  

  • 15. Late-onset Krabbe disease (globoid cell leukodystrophy): clinical and biochemical features of 15 cases.
    Kolodny EH; Raghavan S; Krivit W
    Dev Neurosci; 1991; 13(4-5):232-9. PubMed ID: 1817026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biochemical diagnosis of globoid cell leukodystrophy (Krabbe's disease)].
    Tsvetkova IV; Zolotukhina TV; Rozenfel'd RA
    Vopr Med Khim; 1985; 31(2):128-30. PubMed ID: 2860752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudodeficiencies of arylsulfatase A and galactocerebrosidase activities.
    Wenger DA; Louie E
    Dev Neurosci; 1991; 13(4-5):216-21. PubMed ID: 1687777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Globoid cell (Krabbe's) leukodystrophy: heterozygote detection in cultured skin fibroblasts.
    Farrell DF; Percy AK; Kaback MM; McKhann GM
    Am J Hum Genet; 1973 Nov; 25(6):604-9. PubMed ID: 4773478
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.
    Kudoh T; Wenger DA
    J Clin Invest; 1982 Jul; 70(1):89-97. PubMed ID: 6806321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of mixed dispersion of fluorescent galactosylceramide and sodium dodecylsulfate for assaying galactosylceramide-beta-galactosidase and diagnosing Krabbe disease.
    Salvayre R; Gatt S
    Enzyme; 1985; 33(3):175-80. PubMed ID: 4054076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.